Sandoz Group AG (LON:0SAN)
London · Delayed Price · Currency is GBP · Price in CHF 50.43
+0.27 (0.54%)
At close: Aug 27, 2025
Sandoz Group AG Company Description
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.
The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology.
It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland.
Sandoz Group AG
| Country | Switzerland |
| Founded | 1886 |
| Industry | Medical - Pharmaceuticals |
| Sector | Healthcare |
| Employees | 22,049 |
| CEO | Richard Saynor |
Contact Details
Address: Centralbahnstrasse 4 Basel, 4051 Switzerland | |
| Phone | 41 61 324 11 11 |
| Website | sandoz.com |
Stock Details
| Ticker Symbol | 0SAN |
| Exchange | London Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | CH1243598427 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Richard Saynor | Chief Executive Officer |
| Remco Steenbergen | Chief Financial Officer |
| Craig Marks | Head of Investor Relations |